|Articles|March 1, 2019
- Pharmaceutical Executive-03-01-2019
- Volume 39
- Issue 3
Pharmaceutical Executive, March 2019 Issue (PDF)
Click the title above to open the Pharmaceutical Executive March 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 7 years ago
Patient Advocacy: The Corporate Mandateover 7 years ago
Patient Support Programs: Cost, Benefit, and Resourcingover 7 years ago
Patients is a Virtueover 7 years ago
What Does Patient Centricity Look Like?over 7 years ago
John Crowley: Living the Missionover 7 years ago
Research Bonds Strengthenover 7 years ago
Parallel Trade a Victim of Brexit Collateral Damageover 7 years ago
Multiple Pharma Issues Top Congressional Agendaover 7 years ago
Pharm Exec Joins MJH Portfolioover 7 years ago
Cystic Fibrosis: The Importance of Patient AdvocacyAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Lipfendra to reduce LDL-C in Adults with Hypercholesterolemia
2
Jasper Therapeutics to Acquire Kira Pharmaceuticals in $132 Million Merger Agreement
3
Pharmaceutical Executive Daily: FDA Approves Lipfendra
4
From Dr. Google to Dr. Claude: Why the Most Important Patient Support Innovation Is Still Human Connection
5